FDA-Drug2020-10-07Class IIPROCESSING DEFECT
Strides Pharma potassium chloride tablets recalled for failed dissolution
OTHERNationwide distribution
Stop using Strides potassium chloride tablets
Strides Pharma is recalling specific bottles of potassium chloride extended-release tablets (8mEq, 600 mg) because they failed to meet dissolution specifications—meaning the tablets may not break down in your body as intended. This could affect how well the medication works. The affected bottles have lot number 7240675A with an expiration date of 12/31/2021.
- Stop taking this medication if you have a bottle with lot number 7240675A and expiration date 12/31/2021.
- Contact your pharmacist or doctor for a replacement prescription.
- Do not flush or throw the medication in the trash; ask your pharmacist how to safely dispose of it.
Hazard
Failed Dissolution Specifications
Sold states
nationwide
Affected count
11,280 bottles
Manufactured in
201 S Main St Ste 3, N/A, Lambertville, NJ, United States
Products
Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma Science Limited Bengaluru -562106 India Distributed by: Strides Pharma Inc., East Brunswick NJ 08816 NDC 64380-860-06
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0001-2021Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief